SRx Health Solutions (SRXH) Investor Presentation summary
Event summary combining transcript, slides, and related documents.
Investor Presentation summary
8 Dec, 2025Leadership and vision
Led by experienced executives with backgrounds in pharmacy, finance, and consumer brands, including a founder with over 24 years in healthcare and a CFO skilled in M&A and public company growth.
Leadership team has a track record of scaling businesses, executing successful turnarounds, and driving strategic acquisitions.
Business model and operations
Operates 20 specialty pharmacies, 34 clinics, and 4 clinical trial sites across Canada, with a growing presence in the US.
Provides integrated specialty healthcare services, including pharmacy, clinical support, patient programs, wholesale distribution, and clinical research.
Focuses on patient-centric care for chronic diseases, leveraging a network of healthcare professionals and advanced support systems.
Strategic growth and expansion
Acquired Choice Specialty Pharmacy Group, adding five Texas sites and licenses to distribute in 26 US states, with plans for further US expansion.
Second warehouse in Calgary to be operational in fiscal 2025, supporting distribution growth.
Pursuing high-impact M&A to enhance capabilities and expand markets.
Latest events from SRx Health Solutions
- $2.8M sales, $13.1M cash, $18M digital assets, and EMJX deal drive 2026 growth outlook.SRXH
Q1 20263 Mar 2026 - Merger creates a global health and wellness platform with strong growth and expansion plans.SRXH
2024 Sidoti Virtual Micro-Cap Conference3 Feb 2026 - Q2 2024 net income surged 190% on margin gains and a $3.6M debt extinguishment gain.SRXH
Q2 20241 Feb 2026 - $125M all-stock deal expands into veterinary medicine with strong growth and synergy prospects.SRXH
M&A Announcement19 Jan 2026 - Returned to profitability with 33% sales growth and strong Asia-Pacific and margin gains.SRXH
Q3 202414 Jan 2026 - Q4 revenue up 26%, gross margin at 36%, and net loss nearly break-even for the year.SRXH
Q4 202426 Dec 2025 - All proposals, including the SRx acquisition and name change, were approved by stockholders.SRXH
EGM 202524 Dec 2025 - Pet wellness firm pivots to Halo brand, registers 187M+ shares amid ongoing losses and dilution risk.SRXH
Registration Filing23 Dec 2025 - Pet wellness firm pivots from healthcare, seeks $1B ELOC amid losses and dilution risk.SRXH
Registration Filing10 Dec 2025